S Bezares
Overview
Explore the profile of S Bezares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de la Cruz-Merino L, Gion M, Cruz J, Alonso-Romero J, Quiroga V, Moreno F, et al.
BMC Cancer
. 2022 Dec;
22(1):1258.
PMID: 36463104
Background: We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and the pyrimidine antimetabolite gemcitabine in HER2- advanced breast cancer (ABC) patients previously treated in the...
2.
Albanell J, Martinez M, Ramos M, OConnor M, de la Cruz-Merino L, Santaballa A, et al.
Eur J Cancer
. 2021 Dec;
161:26-37.
PMID: 34902765
Background: The potential benefit of adding palbociclib to fulvestrant as first-line treatment in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative endocrine-sensitive advanced breast cancer (ABC) patients remains...
3.
Alvarez-Lopez I, Bezares S, Dalmau Portulas E, Garcia-Martinez E, Garcia-Saenz J, Gil-Gil M, et al.
Clin Transl Oncol
. 2020 Feb;
22(8):1364-1377.
PMID: 32052382
Purpose: Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on...
4.
Cea-Calvo L, Bezares S, Berbel A, Ruiz-Morales J, Gonzalez C
Rev Clin Esp
. 2000 Mar;
200(1):51-2.
PMID: 10721298
No abstract available.